These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31685150)

  • 1. Sequence of Splenectomy and Rituximab for the Treatment of Steroid-Refractory Immune Thrombocytopenia: Does It Matter?
    Hammond WA; Vishnu P; Rodriguez EM; Li Z; Dholaria B; Shreders AJ; Rivera CE
    Mayo Clin Proc; 2019 Nov; 94(11):2199-2208. PubMed ID: 31685150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune thrombocytopenia: Effectiveness of frontline steroids and comparison of azathioprine, splenectomy, and rituximab as second-line treatment.
    Chang H; Tang TC; Hung YS; Li PL; Kuo MC; Wu JH; Wang PN
    Eur J Haematol; 2018 Oct; 101(4):549-555. PubMed ID: 30007087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenectomy vs. rituximab as a second-line therapy in immune thrombocytopenic purpura: a single center experience.
    Al Askar AS; Shaheen NA; Al Zahrani M; Al Otaibi MG; Al Qahtani BS; Ahmed F; Al Zughaibi M; Kamran I; Mendoza MA; Khan A
    Int J Hematol; 2018 Jan; 107(1):69-74. PubMed ID: 28895035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
    Zhang C; Liu HF; Chen XH; Gao L; Gao L; Liu Y; Kong PY; Sun AH; Zhang X
    Clin Ther; 2014 Mar; 36(3):385-8. PubMed ID: 24594069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults.
    Kikuchi K; Miyakawa Y; Ikeda S; Sato Y; Takebayashi T
    BMC Health Serv Res; 2015 Jan; 15():2. PubMed ID: 25609557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reemergence of Splenectomy for ITP Second-line Treatment?
    Chater C; Terriou L; Duhamel A; Launay D; Chambon JP; Pruvot FR; Rogosnitzky M; Zerbib P
    Ann Surg; 2016 Nov; 264(5):772-777. PubMed ID: 27741009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients.
    Aleem A
    Platelets; 2011; 22(1):1-7. PubMed ID: 20964585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern Anatolia.
    Kaya E; Erkurt MA; Aydogdu I; Kuku I; Ozhan O; Oner RI; Ulutas O
    Med Princ Pract; 2007; 16(2):100-6. PubMed ID: 17303943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenectomy for immune thrombocytopenia: down but not out.
    Chaturvedi S; Arnold DM; McCrae KR
    Blood; 2018 Mar; 131(11):1172-1182. PubMed ID: 29295846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult Primary Immune Thrombocytopenia: Spleen Histology Findings and Outcomes According to Rituximab Use Based on Analysis of 41 Cases.
    Furudoï A; Rivière É; Lazaro E; Furudoï E; Viallard JF; Parrens M
    Am J Surg Pathol; 2018 Mar; 42(3):401-412. PubMed ID: 29200102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ITP and international guidelines: what do we know, what do we need?
    Rodeghiero F; Ruggeri M
    Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient Management of Patients with Immune Thrombocytopenia (ITP) by Hematologists 1995-2014.
    Weide R; Feiten S; Friesenhahn V; Heymanns J; Kleboth K; Thomalla J; van Roye C; Köppler H
    Oncol Res Treat; 2016; 39(1-2):41-4. PubMed ID: 26891217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of patients treated with rituximab as second-line treatment for adult immune thrombocytopenia - Follow-up of the RITP study.
    Tjønnfjord E; Holme PA; Darne B; Khelif A; Waage A; Michel M; Ben Romdhan N; Ghanima W
    Br J Haematol; 2020 Nov; 191(3):460-465. PubMed ID: 32342497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment outcome of immune thrombocytopenia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2012 Oct; 153(41):1613-21. PubMed ID: 23045311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New treatment methods for autoimmune thrombocytopenia].
    Koene HR
    Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2609-14. PubMed ID: 18161261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.